Measuring Quality and Safety of Epilepsy Monitoring Units In Brazil: Adoption of Quality Indicators

Epilepsy is a prevalent neurologic condition worldwide, with estimated lifetime prevalence rates of 5.8 per 1,000 in developed countries and 10.3 per 1,000 in urban areas and 15.4 per 1,000 in rural areas of developing countries [1]. However, due to variations in study methodology and limited data in many parts of the developing world, the true prevalence of epilepsy remains uncertain [1,2]. Brazil, in particular, lacks comprehensive data; however, published reports estimate the lifetime prevalence of epilepsy to be between 9.2 and 18.6 per 1,000, similar to other low-income countries [3–6].

0